Início › Câncer Endometrial › Pensilvânia › Pittsburgh
Ensaios clínicos de Câncer Endometrial em Pittsburgh, PA
23 estudos para Câncer Endometrial estão buscando participantes em locais em Pittsburgh e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecrutandoFase 2
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- e mais 3
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecrutandoFase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Distance-Based Exercise to Preserve Function and Prevent Disability
Recrutando
- UPMC Hillman Cancer Center, Pittsburgh
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecrutandoFase 3
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- UPMC Cancer Center-Washington, Washington · a 23 mi de distância
- e mais 1
A Phase 1 Study of the Safety and Tolerability of CTX-10726
RecrutandoFase 1
- UPMC Hillman Cancer Center, Pittsburgh
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
RecrutandoFase 2
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- UPMC-Mercy Hospital, Pittsburgh
- e mais 12
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
RecrutandoFase 1
- Research Site, Pittsburgh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecrutandoFase 1/2
- Allegheny Health Network, Pittsburgh
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RecrutandoFase 1
- University of Pittsburgh Medical Center, Pittsburgh
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
RecrutandoFase 3
- AHN West Penn Hospital ( Site 6006), Pittsburgh
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RecrutandoFase 1/2
- Research Site, Pittsburgh
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RecrutandoFase 3
- Research Site, Pittsburgh
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
RecrutandoFase 1
- UPMC Hillman Cancer Center, Pittsburgh
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecrutandoFase 1/2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RecrutandoFase 1
- UPMC, Pittsburgh
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
RecrutandoFase 2
- West Penn Hospital, Pittsburgh
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecrutandoFase 1/2
- Allegheny Health Network, Pittsburgh
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RecrutandoFase 3
- Research Site, Pittsburgh
- Research Site, Pittsburgh
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RecrutandoFase 2
- 127, Pittsburgh
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
RecrutandoFase 2
- West Penn Allegheny Health, Pittsburgh
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
RecrutandoFase 2
- West Penn Hospital, Pittsburgh
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
RecrutandoFase 2
- Allegheny Health, Pittsburgh
Ensaios de Câncer Endometrial em outras cidades
- Houston, TX68 estudos
- New York City, NY52 estudos
- Boston, MA50 estudos
- Arlington, VA39 estudos
- Nashville, TN38 estudos
- Los Angeles, CA34 estudos
- St. Louis, MO29 estudos
- Philadelphia, PA28 estudos
- San Antonio, TX27 estudos
- Chicago, IL25 estudos
- Columbus, OH25 estudos
- Queens, NY25 estudos
Outros estudos em Pittsburgh
- Câncer de Pulmão de Não Pequenas Células48 estudos
- Câncer (todos os tipos)41 estudos
- Câncer de Mama39 estudos
- Câncer Colorretal32 estudos
- Câncer Metastático31 estudos
- Melanoma31 estudos
- Câncer de Ovário30 estudos
- Câncer de Pulmão23 estudos
- Câncer de Próstata23 estudos
- Acidente Vascular Cerebral22 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço22 estudos
- Depressão22 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.